Medtech | Ophthalmology Innovation Source

Avedro Broadens Cross-Link Product Line

Corneal collagen cross-linking has been a vexing specialty for US-based companies trying to guide a product through a cautious FDA. But Massachusetts-based Avedro Inc., continues to establish a meaningful portfolio in the space through deals like the acquisition of Switzerland-based IROC Innocross AG. Avedro acquired the assets of IROC Innocross, which was the first company…

Lindstrom: Ophthalmologists Facing Both Opportunity & Pressure

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 005″] Richard L. Lindstrom, MD, a long-time supporter of ophthalmology start-ups, looks ahead at the challenges facing physicians and investors as they work to meet the growing demand for ophthalmic treatment in an evolving healthcare industry. Podcast Guest Richard Lindstrom, MD Dr Richard L Lindstrom, Founder and attending surgeon at Minnesota…

Cunningham: Strong Signs Ahead For Ophthalmology Innovation

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 004″] OIS Co-Chair, Emmett T. Cunningham, Jr., MD, recounts the origin of the Ophthalmology Innovation Summits and his time at the formative Eyetech Pharmaceuticals, while sharing in earnest his hopes for ophthalmology as an industry. Podcast Guest Emmett T. Cunningham Jr., MD, PhD, MPH Dr. Cunningham joined Clarus Ventures with 20+…

Donnenfeld Bullish on Ophthalmic Innovation

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 003″] Eric Donnenfeld, MD, former president of ASCRS, explains technology has profoundly changed how ophthalmology is delivered. He also shares some of his priority issues while he was president of the ASCRS including training the next generation of ophthalmic surgeons. Podcast Guest Eric Donnenfeld Dr. Donnenfeld is a Clinical Professor of…

Link Says Versant’s Eyes Will Be On Ophthalmology

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 002″] Bill Link explains why ophthalmology will continue to be a pillar for Versant’s new fund. He also talks about the impact of industry consolidation, the Sunshine Act, and he offers helpful advice to entrepreneurs and physicians looking to turn inspiration into innovation. Podcast Guest William J. Link, PhD Bill was…

Mazzo Muses On The FDA, Google & Failing Fast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 001″] Jim Mazzo, Chairman and CEO of AcuFocus, offers his insights on why ophthalmology remains a standout sector in life sciences and what investors and entrepreneurs need to do to find success in Medtech. Also, what should we make of Google’s contact lens deal with Novartis? Podcast Guest Jim Mazzo Jim…

2014 OIS@ASCRS Executive Report

BOSTON — The Third Annual Ophthalmology Innovation Summit (OIS@ASCRS) took place on April 24, just prior to the 2014 annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS). The purpose of this conference is to support innovation by facilitating deal-flow and business partnerships between CEOs of young companies, investors, corporate executives, physicians,…

EyeSonix

Donald Schwartz talks about TUG, which is the only ultrasound treatment designed for all open angle glaucoma. Presenter: Donald Schwartz Donald Schwartz is a comprehensive ophthalmologist in practice in Long Beach CA. He is on the clinical faculty of both USC and UC Irvine where he has taught cataract surgery and optics and refraction for…

OIS@AAO 2013 Executive Summary

More than 800 attendees participated in the fifth annual Ophthalmology Innovation Summit, held November 14, 2013, just prior to the annual meeting of the American Academy of Ophthalmology in New Orleans, LA. The full-day focus on innovation in ophthalmology included private pharmaceutical and device company showcases and stimulating discussions with venture capitalists, specialists in public…

The Ophthalmology Market – “A View from the Public Sector”

Jeffrey Hoffman, Managing Director and Head of West Coast Healthcare Investment Banking for JPMorgan, gladly addresses the audience at the 5th Annual Ophthalmology Innovation Summit with a promising outlook. Expanding on the rise of individual company risks, Jeffrey shares specific increases in the biotech and life sciences markets, as they recover from a 10-year lull.…

FDA Focus on More Efficient Processing Yields Faster Decisions

SAN FRANCISCO — The U.S. Food and Drug Administration has been criticized for its ponderous movement of potential drugs and medical devices through the approval process. Recognizing this criticism, and following implementation of the Medical Devices User Fee and Modernization Act of 2002 and subsequent internal reevaluations and reorganizations, the FDA approval process for innovative…